Avricore Health (Avricore Health) Debt-to-Equity : 0.02 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Avricore Health Debt-to-Equity?

Avricore Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.03 Mil. Avricore Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Avricore Health's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $1.50 Mil. Avricore Health's debt to equity for the quarter that ended in Dec. 2023 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Avricore Health's Debt-to-Equity or its related term are showing as below:

AVCRF' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.4 Med: 0.02 Max: 0.05
Current: 0.02

During the past 13 years, the highest Debt-to-Equity Ratio of Avricore Health was 0.05. The lowest was -1.40. And the median was 0.02.

AVCRF's Debt-to-Equity is ranked better than
93.26% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs AVCRF: 0.02

Avricore Health Debt-to-Equity Historical Data

The historical data trend for Avricore Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health Debt-to-Equity Chart

Avricore Health Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-0.05

-1.40

0.02

Avricore Health Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.02	0.02	0.02	0.02	0.02

Competitive Comparison of Avricore Health's Debt-to-Equity

For the Diagnostics & Research subindustry, Avricore Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avricore Health's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Avricore Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Avricore Health's Debt-to-Equity falls into.

Avricore Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Avricore Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.03	+	0)	/	1.497
	=	0.02

Avricore Health's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.03	+	0)	/	1.497
	=	0.02

Avricore Health (OTCPK:AVCRF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Avricore Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Avricore Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Avricore Health (Avricore Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (OTCPK:AVCRF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

8VP1:Germany AVCR:Canada

Address

1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2

Website

https://www.avricorehealth.com

Avricore Health Inc is a Canada based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and sale of testing panels.